Free Trial
ASX:AYA

Artrya (AYA) Stock Price, News & Analysis

Artrya logo

About Artrya Stock (ASX:AYA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$78.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Receive AYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artrya and its competitors with MarketBeat's FREE daily newsletter.

AYA Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
Automobiles And Trucks
Current Symbol
ASX:AYA
CIK
N/A
Fax
N/A
Employees
19,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$197,000.00
Price / Cash Flow
N/A
Book Value
A$0.21 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$78.67 million
Optionable
Not Optionable
Beta
0.71
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:AYA) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners